Background—Although most clinical trials of coronary stents have measured nominally
identical safety and effectiveness end points, differences in definitions and timing of …

The cellular and molecular processes that control vascular injury responses after
percutaneous coronary intervention involve a complex interplay among vascular cells and …

Objectives: This study examined human drug-eluting stents (DES) to determine the long-
term effects of these stents on coronary arterial healing and identified mechanisms …

Background Clopidogrel and aspirin are the most commonly used antiplatelet therapies for
percutaneous coronary intervention (PCI). We assessed the effect of various clopidogrel and …

Background Stent thrombosis is a safety concern associated with use of drug-eluting stents.
Little is known about occurrence of stent thrombosis more than 1 year after implantation of …

The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

Background The safety of drug-eluting stents has been called into question by recent reports
of increased stent thrombosis, myocardial infarction, and death. Such studies have been …

The objective of this review is to describe the suitability of different biomaterials as coronary
stents. This review focuses on the following topics:(1) different materials used for stents,(2) …

Coronary artery stents revolutionized the practice of interventional cardiology after they were
first introduced in the mid-1980s. Since then, there have been significant developments in …

Although rare, stent thrombosis remains a severe complication after stent implantation owing
to its high morbidity and mortality. Since the introduction of drug-eluting stents (DES), most …